Weight-Loss Drug Demand Skyrockets: Drugmaker Novo Nordisk Struggles to Meet Supply for Wegovy
New York, USA – Novo Nordisk has reported a significant increase in the supply of its popular weight-loss drug Wegovy, with approximately 25,000 individuals in the United States starting the medication each week. This surge in demand, which the Danish pharmaceutical giant attributes to a fourfold rise since December, has led to supply shortages as the company grapples with meeting consumer needs. Novo Nordisk CEO Lars Fruergaard Jorgensen acknowledged the overwhelming demand, stating that it …